Address
Road no. 4, Vatara, Notun Bazar
Dhaka, Bangladesh
Address
Road no. 4, Vatara, Notun Bazar
Dhaka, Bangladesh

Brand Name: Daconib
Generic Name: Dacomitinib
Strength: 45 mg
Volume: 30 tablets
Manufacturer: Everest Pharmaceuticals
Daconib (Dacomitinib 45 mg tablet) is an oral small-molecule kinase inhibitor. It was approved by the FDA on September 27, 2018, for the first-line treatment of non-small cell lung cancer in adult patients with epithelial growth factor receptor (EGFR) exon 19 deletion mutation or exon 21 L858R substitution.
Dacomatinib has been approved for the first-line treatment of adult patients with metastatic non-small cell lung cancer with an FDA-approved test and whose tumors have an EGFR exon 19 deletion or exon 21 L858R substitution mutation. Continue the medication until disease progression or unacceptable toxicity.
Daconib 45 mg is an irreversible inhibitor (that permanently blocks the action of an enzyme by forming a strong bond with it) of the human EGFR family (EGFR/HER1, HER2, and HER4) and certain EGFR activating mutations (exon 19 deletion or the exon 21 L858R substitution mutation). By blocking those enzymes, it helps slow down the growth of tumors and leads cancer cells to the death. In clinical trials, it has shown improvement compared to Gefitinib in patients with EGFR-mutant metastatic NSCLC.
Store at controlled room temperature: about 20 °C to 25 °C. Keep the medication in the original container away from moisture, light, and out of reach of children. Do not share with others, even if they have a similar condition.
Daconib 45 mg (generic Dacomatinib) price in Bangladesh depends on brand, manufacturer, and region. Cost may vary due to the duration of the treatment. Discuss with the authorized distributor of Dacomatinib in Bangladesh for exact cost information.
Dacomatinib is a prescription-only medicine that is not directly available for online purchase. Request a query to the manufacturer or authorized distributor to get this prescription medicine online.
According to the FDA label, the half-life of Daconib 45 mg tablets is 70-100 hours in patients. Practically, this means that the drug and its effects may exist for several days (a week or more) after the last dose. However, “staying in the system” does not equal “effectively active” for the full time; the therapeutic and toxic effects may diminish progressively. Complete elimination may take 2-3 weeks in many patients, but it may vary for individuals.
Yes, Generic Dacomitinib (Daconib 45 mg) is available in Asia, manufactured by Everest Pharmaceuticals, where it is approved by their drug administration.
Reviews
There are no reviews yet.